Dian Diagnostics (300244.SZ) released its performance for the first three quarters, with a net profit attributable to the parent company of 482 million yuan, a year-on-year increase of 750.28%.

Zhitong Finance APP News, Dian Diagnostics (300244.SZ) released its 2026 third-quarter report. From January to September 2026, the company achieved operating revenue of 7.409 billion yuan, a year-on-year decrease of 2.07%; net profit attributable to shareholders of the listed company was 482 million yuan, a year-on-year increase of 750.28%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 418 million yuan, a year-on-year increase of 1,074.80%; basic earnings per share were 0.789 yuan.